Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD

Phase 3 program enrolled 1,984 patients across COAST and ShORe trials

Trials designed to replicate superiority in visual outcomes demonstrated in Phase 2b

Read more at globenewswire.com